Source comparison
PT-141 Needles Syringes: Configuration Comparison
The table below compares the most common PT-141 needles syringes configurations used in research settings, evaluating each on tissue trauma, dead space waste, ease of aspiration, and suitability for subcutaneous bremelanotide administration. 0.3mL Insulin Syri
This comparison does not assign a generated winner or score.
- The table below compares the most common PT-141 needles syringes configurations used in research settings, evaluating each on tissue trauma, dead space waste, ease of aspiration, and suitability for subcutaneous bremelanotide administration.
- 0.3mL Insulin Syringe (Integrated 29G × 12.7mm)
- 29G, 12.7mm (½ inch)
- 0.01–0.02mL
- Moderate. Requires slow draw to avoid air bubbles
- Excellent for lean to average body composition; may reach muscle in very lean individuals at 90° angle
- Optimal for dose volumes ≤0.3mL; minimal waste, fine gauge reduces site reactions
- 0.5mL Insulin Syringe (Integrated 28G × 8mm)
- 28G, 8mm (5/16 inch)
- Good. Slightly wider bore allows easier draw without excessive shear
- Excellent for most subcutaneous sites; 8mm length avoids IM injection risk in nearly all users
- Best all-around choice for PT-141 doses 0.1–0.5mL; balances precision, comfort, and peptide stability
- 1mL Luer-Lock Syringe + Detachable 27G × 12.7mm
- 27G, 12.7mm
- 0.06–0.08mL
- Excellent. Wide bore, easy aspiration
- Good if injected at 45° angle; risk of IM penetration at 90° in lean tissue
- Higher dead space waste (up to 0.08mL/injection); acceptable only if needle is changed between draw and injection to use finer gauge for administration
- 0.3mL Insulin Syringe (Integrated 30G × 8mm)
- 30G, 8mm
- Difficult. Very fine gauge requires slow, controlled draw; risk of peptide shear if drawn too quickly
- Excellent for shallow subcutaneous injection; minimal trauma, ideal for frequent administration sites
- Best for users prioritizing injection comfort and site preservation; slower draw technique required to protect peptide integrity
- 3mL Luer-Lock Syringe + 25G × 16mm (Standard IM Configuration)
- 25G, 16mm (⅝ inch)
- 0.10–0.12mL
- Excellent. Large bore, fast draw
- Poor. Length and gauge designed for intramuscular injection; exceeds subcutaneous depth in most sites
- Not recommended for PT-141; excessive dead space, tissue trauma, and risk of unintended IM administration
- The 0.5mL insulin syringe with integrated 28G × 8mm needle represents the optimal configuration for most PT-141 subcutaneous protocols: dead space under 0.02mL per injection, needle length appropriate for subcutaneous depth without IM risk, and gauge fine enough to minimize site reactions while wide enough to allow controlled aspiration without excessive peptide shear. Researchers administering doses above 0.5mL may require 1mL insulin syringes, but should verify that incremental markings provide adequate measurement precision for their target dose.